Int J Clin Exp Med 2015;8(9):15340-15350 www.ijcem.com /ISSN:1940-5901/IJCEM0011366 Original Article

Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.

ZINZANI, PIER LUIGI
GANDOLFI, LETIZIA
BROCCOLI, ALESSANDRO
ARGNANI, LISA
FANTI, STEFANO
PELLEGRINI, CINZIA
STEFONI, VITTORIO
DERENZINI, ENRICO
QUIRINI, FEDERICA
BACCARANI, MICHELE

January 2011

BACKGROUND: The use of (18) F-fluorodeoxyglucose positron-emission tomography (PET) scan has incr...

Outcome prediction by extranodal involvement, IPI, and R-IPI in the PET/CT and rituximab era:A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma

El-Galaly, Tarec Christoffer
Villa, Diego
Alzahrani, Musa
Hansen, Jakob Werner
Sehn, Laurie H
Wilson, Don
de Nully Brown, Peter
Loft, Annika
Iyer, Victor
Johnsen, Hans Erik
Savage, Kerry J
Connors, Joseph M
Hutchings, Martin

January 2015

PURPOSE: 18F-fluorodeoxyglucose PET/CT (PET/CT) is the current state-of-the-art in the staging of di...

An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma

Adams, Hugo J. A.
Kwee, Thomas C.

December 2017

Assessing response to therapy in lymphoma is important for determining patients' prognosis, guiding ...

Review Article The Predictive Value of Interim and Final [18F] Fluorodeoxyglucose Positron Emission Tomography after Rituximab-Chemotherapy in the Treatment of Non-Hodgkin’s Lymphoma: A Meta-Analysis

Yuyuan Zhu
A Lu
Xin Wei
Shaoli Song
Gang Huang

August 2016

which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...

Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma : Systematic review and meta-analysis

Adams, Hugo J A
Kwee, Thomas C.

October 2016

This study aimed to systematically review and meta-analyze the prognostic value of interim 18F-fluor...

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis

Burggraaff, Coreline N.
de Jong, Antoinette
Hoekstra, Otto S.
Hoetjes, Nikie J.
Nievelstein, Rutger A. J.
Jansma, Elise P.
Heymans, Martijn W.
de Vet, Henrica C. W.
Zijlstra, Josée M.

January 2019

Purpose: Diffuse large B-cell lymphoma (DLBCL) represents the most common subtype of non-Hodgkin lym...

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma : a systematic review and meta-analysis

Burggraaff, Coreline N.
de Jong, Antoinette
Hoekstra, Otto S.
Hoetjes, Nikie J.
Nievelstein, Rutger A.J.
Jansma, Elise P.
Heymans, Martijn W.
de Vet, Henrica C.W.
Zijlstra, Josée M.

January 2019

Purpose: Diffuse large B-cell lymphoma (DLBCL) represents the most common subtype of non-Hodgkin lym...

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Pregno P
Chiappella A
Bellò M
Botto B
Ferrero S
Franceschetti S
Giunta F
Ladetto M
Limerutti G
Menga M
Nicolosi M
Priolo G
Puccini B
Rigacci L
Salvi F
Vaggelli L
Passera R
Bisi G
Vitolo U

January 2012

Role of interim-PET (I-PET) in diffuse large B-cell Lymphoma (DLBCL) is controversial. To determine ...

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

M. Martelli
L. Ceriani
E. Zucca
P. L. Zinzani
A. J. M
U. Vitolo
C. Stelitano
E. Brusamolino
M. G. Cabras
L. Rigacci
M. Balzarotti
F. Salvi
S. Montoto
A. Lopez Guillermo
E. Finolezzi
S. A. Pileri
A. Davies
F. Cavalli
L. Giovanella
P. W. M.

January 2014

PURPOSE: To assess the role of [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/comp...

[<sup>18</sup>F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study

Martelli, Maurizio
Ceriani, Luca
Zucca, Emanuele
Zinzani, Pier Luigi
Ferreri, Andrés J.M.
Vitolo, Umberto
Stelitano, Caterina
Brusamolino, Ercole
Cabras, Maria Giuseppina
Rigacci, Luigi
Balzarotti, Monica
Salvi, Flavia
Montoto, Silvia
Lopez-Guillermo, Armando
Finolezzi, Erica
Pileri, Stefano A.
Davies, Andrew
Cavalli, Franco
Giovanella, Luca
Johnson, Peter W.M.

June 2014

PURPOSE: To assess the role of [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/compu...

Research Article Detailed Analysis of Diffuse Large B Cell Lymphoma Patients: A Single-Center, Retrospective Study

Isrn Hematology
Onder Ergonul
Burhan Ferhanoglu

January 2013

Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma : Systematic review and meta-analysis

Adams, Hugo J A
Nievelstein, Rutger A J
Kwee, Thomas C.

January 2015

This study systematically reviewed and meta-analysed the prognostic value of complete remission stat...

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

Mamot, Christoph
Klingbiel, Dirk
Hitz, Felicitas
Renner, Christoph
Pabst, Thomas
Driessen, Christoph
Mey, Ulrich
Pless, Miklos
Bargetzi, Mario
Krasniqi, Fatime
Gigli, Federica
Hany, Thomas
Samarin, Andrei
Biaggi, Christine
Rusterholz, Corinne
Dirnhofer, Stephan
Zucca, Emanuele
Martinelli, Giovanni

August 2015

PURPOSE Our main objective was to prospectively determine the prognostic value of [(18)F]fluorode...

Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.

Cox, MC
Lanni, V
Cavalieri, E
Pelliccia, S
Scopinaro, F
Monarca, B
Marchetti, P
Spiriti, M.A.
AMBROGI, VINCENZO

January 2012

In diffuse large B-cell lymphoma (DLBCL), the response to first-line immunochemotherapy remains some...

FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study

Mikhaeel, N. George
Cunningham, David
Counsell, Nicholas
McMillan, Andrew
Radford, John A.
Ardeshna, Kirit M.
Lawrie, Anthony
Smith, Paul
Clifton-Hadley, Laura
O'Doherty, Michael J.
Barrington, Sally F.

July 2020

The UK National Cancer Research Institute initiated a prospective study (UKCRN-ID 1760) to assess th...

Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.

ZINZANI, PIER LUIGI
GANDOLFI, LETIZIA
BROCCOLI, ALESSANDRO
ARGNANI, LISA
FANTI, STEFANO
PELLEGRINI, CINZIA
STEFONI, VITTORIO
DERENZINI, ENRICO
QUIRINI, FEDERICA
BACCARANI, MICHELE

January 2011

BACKGROUND: The use of (18) F-fluorodeoxyglucose positron-emission tomography (PET) scan has incr...

Outcome prediction by extranodal involvement, IPI, and R-IPI in the PET/CT and rituximab era:A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma

El-Galaly, Tarec Christoffer
Villa, Diego
Alzahrani, Musa
Hansen, Jakob Werner
Sehn, Laurie H
Wilson, Don
de Nully Brown, Peter
Loft, Annika
Iyer, Victor
Johnsen, Hans Erik
Savage, Kerry J
Connors, Joseph M
Hutchings, Martin

January 2015

PURPOSE: 18F-fluorodeoxyglucose PET/CT (PET/CT) is the current state-of-the-art in the staging of di...

An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma

Adams, Hugo J. A.
Kwee, Thomas C.

December 2017

Assessing response to therapy in lymphoma is important for determining patients' prognosis, guiding ...

Review Article The Predictive Value of Interim and Final [18F] Fluorodeoxyglucose Positron Emission Tomography after Rituximab-Chemotherapy in the Treatment of Non-Hodgkin’s Lymphoma: A Meta-Analysis

Yuyuan Zhu
A Lu
Xin Wei
Shaoli Song
Gang Huang

August 2016

which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...

Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma : Systematic review and meta-analysis

Adams, Hugo J A
Kwee, Thomas C.

October 2016

This study aimed to systematically review and meta-analyze the prognostic value of interim 18F-fluor...

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis

Burggraaff, Coreline N.
de Jong, Antoinette
Hoekstra, Otto S.
Hoetjes, Nikie J.
Nievelstein, Rutger A. J.
Jansma, Elise P.
Heymans, Martijn W.
de Vet, Henrica C. W.
Zijlstra, Josée M.

January 2019

Purpose: Diffuse large B-cell lymphoma (DLBCL) represents the most common subtype of non-Hodgkin lym...

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma : a systematic review and meta-analysis

Burggraaff, Coreline N.
de Jong, Antoinette
Hoekstra, Otto S.
Hoetjes, Nikie J.
Nievelstein, Rutger A.J.
Jansma, Elise P.
Heymans, Martijn W.
de Vet, Henrica C.W.
Zijlstra, Josée M.

January 2019

Purpose: Diffuse large B-cell lymphoma (DLBCL) represents the most common subtype of non-Hodgkin lym...

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Pregno P
Chiappella A
Bellò M
Botto B
Ferrero S
Franceschetti S
Giunta F
Ladetto M
Limerutti G
Menga M
Nicolosi M
Priolo G
Puccini B
Rigacci L
Salvi F
Vaggelli L
Passera R
Bisi G
Vitolo U

January 2012

Role of interim-PET (I-PET) in diffuse large B-cell Lymphoma (DLBCL) is controversial. To determine ...

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

M. Martelli
L. Ceriani
E. Zucca
P. L. Zinzani
A. J. M
U. Vitolo
C. Stelitano
E. Brusamolino
M. G. Cabras
L. Rigacci
M. Balzarotti
F. Salvi
S. Montoto
A. Lopez Guillermo
E. Finolezzi
S. A. Pileri
A. Davies
F. Cavalli
L. Giovanella
P. W. M.

January 2014

PURPOSE: To assess the role of [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/comp...

[<sup>18</sup>F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study

Martelli, Maurizio
Ceriani, Luca
Zucca, Emanuele
Zinzani, Pier Luigi
Ferreri, Andrés J.M.
Vitolo, Umberto
Stelitano, Caterina
Brusamolino, Ercole
Cabras, Maria Giuseppina
Rigacci, Luigi
Balzarotti, Monica
Salvi, Flavia
Montoto, Silvia
Lopez-Guillermo, Armando
Finolezzi, Erica
Pileri, Stefano A.
Davies, Andrew
Cavalli, Franco
Giovanella, Luca
Johnson, Peter W.M.

June 2014

PURPOSE: To assess the role of [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/compu...

Research Article Detailed Analysis of Diffuse Large B Cell Lymphoma Patients: A Single-Center, Retrospective Study

Isrn Hematology
Onder Ergonul
Burhan Ferhanoglu

January 2013

Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma : Systematic review and meta-analysis

Adams, Hugo J A
Nievelstein, Rutger A J
Kwee, Thomas C.

January 2015

This study systematically reviewed and meta-analysed the prognostic value of complete remission stat...

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

Mamot, Christoph
Klingbiel, Dirk
Hitz, Felicitas
Renner, Christoph
Pabst, Thomas
Driessen, Christoph
Mey, Ulrich
Pless, Miklos
Bargetzi, Mario
Krasniqi, Fatime
Gigli, Federica
Hany, Thomas
Samarin, Andrei
Biaggi, Christine
Rusterholz, Corinne
Dirnhofer, Stephan
Zucca, Emanuele
Martinelli, Giovanni

August 2015

PURPOSE Our main objective was to prospectively determine the prognostic value of [(18)F]fluorode...

Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy.

Cox, MC
Lanni, V
Cavalieri, E
Pelliccia, S
Scopinaro, F
Monarca, B
Marchetti, P
Spiriti, M.A.
AMBROGI, VINCENZO

January 2012

In diffuse large B-cell lymphoma (DLBCL), the response to first-line immunochemotherapy remains some...

FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study

Mikhaeel, N. George
Cunningham, David
Counsell, Nicholas
McMillan, Andrew
Radford, John A.
Ardeshna, Kirit M.
Lawrie, Anthony
Smith, Paul
Clifton-Hadley, Laura
O'Doherty, Michael J.
Barrington, Sally F.

July 2020

The UK National Cancer Research Institute initiated a prospective study (UKCRN-ID 1760) to assess th...

Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.

ZINZANI, PIER LUIGI
GANDOLFI, LETIZIA
BROCCOLI, ALESSANDRO
ARGNANI, LISA
FANTI, STEFANO
PELLEGRINI, CINZIA
STEFONI, VITTORIO
DERENZINI, ENRICO
QUIRINI, FEDERICA
BACCARANI, MICHELE

January 2011

BACKGROUND: The use of (18) F-fluorodeoxyglucose positron-emission tomography (PET) scan has incr...

Outcome prediction by extranodal involvement, IPI, and R-IPI in the PET/CT and rituximab era:A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma

El-Galaly, Tarec Christoffer
Villa, Diego
Alzahrani, Musa
Hansen, Jakob Werner
Sehn, Laurie H
Wilson, Don
de Nully Brown, Peter
Loft, Annika
Iyer, Victor
Johnsen, Hans Erik
Savage, Kerry J
Connors, Joseph M
Hutchings, Martin

January 2015

PURPOSE: 18F-fluorodeoxyglucose PET/CT (PET/CT) is the current state-of-the-art in the staging of di...

An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma

Adams, Hugo J. A.
Kwee, Thomas C.

December 2017

Assessing response to therapy in lymphoma is important for determining patients' prognosis, guiding ...

Int J Clin Exp Med 2015;8(9):15340-15350 www.ijcem.com /ISSN:1940-5901/IJCEM0011366 Original Article

Abstract

Extracted data

Int J Clin Exp Med 2015;8(9):15340-15350 www.ijcem.com /ISSN:1940-5901/IJCEM0011366 Original Article

Abstract

Extracted data

Related items

Related items